Effect of antioxidants on postoperative hyperamylasemia in Coronary bypass surgery
Antioxidants may reduce pancreatic cellular injury after coronary artery bypass grafting (CABG) Twenty patients (Group A) received vitamin E (600 mg/ day) for 28 days and vitamin C (2 g/day) and allopurinol (600 mg/day) 2 days before and 1 day after CABG. Seventeen patients (Group C) received all dr...
Gespeichert in:
Veröffentlicht in: | Pancreas 1996-10, Vol.13 (3), p.236-240 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 240 |
---|---|
container_issue | 3 |
container_start_page | 236 |
container_title | Pancreas |
container_volume | 13 |
creator | PAAJANEN, H HARMOINEN, A SISTO, T TARKKA, M METSÄ-KETELÄ, T IOVANNA, J. L DAGORN, J.-C NORDBACK, I. H |
description | Antioxidants may reduce pancreatic cellular injury after coronary artery bypass grafting (CABG) Twenty patients (Group A) received vitamin E (600 mg/ day) for 28 days and vitamin C (2 g/day) and allopurinol (600 mg/day) 2 days before and 1 day after CABG. Seventeen patients (Group C) received all drugs for 3 days, and 25 (Group B) and 19 (Group D) patients served as corresponding controls. The pre- and postoperative pancreatic isoamylase (P-amylase), creatinine, and antioxidant concentrations were measured. Serum hyperamylasemia was highest on the first postoperative day and occurred in 73% of the patients. After surgery serum P-amylase increased in all study groups and urine P-amylase decreased. Postoperative serum hyperamylasemia, whether primarily renal or pancreatic, cannot be decreased by pretreatment with allopurinol, vitamin C, and vitamin E. |
doi_str_mv | 10.1097/00006676-199610000-00004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78476381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78476381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-fc6a708f26096eaeed56d45a2d187ab9ac14b4810ea3fea40b18d95d20bb7b103</originalsourceid><addsrcrecordid>eNo9UE1LxDAQDaKs6-pPEHIQb9WkSZP0KMv6AQuC6LlM2kQjbVOTVuy_t3XXncN8vjczPIQwJTeU5PKWTCaEFAnNc0HnKpkdP0JLmjGRcJWqY7QkSmUJo1KeorMYPwmhkmX5Ai2UUlxxtkQvG2tN2WNvMbS98z-ummLEvsWdj73vTIDefRv8Mc5pM9YQTeMAuxavffAthBHrsYMYcRzCuwnjOTqxUEdzsY8r9Ha_eV0_Jtvnh6f13TYpmVB9YksBkiibCpILA8ZUmah4BmlFlQSdQ0m55ooSA8wa4ERTVeVZlRKtpaaErdD1bm8X_NdgYl80LpamrqE1foiFVFwKpugEVDtgGXyMwdiiC66ZHi8oKWY5i385i4Ocfy0-US_3NwbdmOpA3Os3za_2c4gl1DZAW7p4gLE05TyT7BeRyH7K</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78476381</pqid></control><display><type>article</type><title>Effect of antioxidants on postoperative hyperamylasemia in Coronary bypass surgery</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>PAAJANEN, H ; HARMOINEN, A ; SISTO, T ; TARKKA, M ; METSÄ-KETELÄ, T ; IOVANNA, J. L ; DAGORN, J.-C ; NORDBACK, I. H</creator><creatorcontrib>PAAJANEN, H ; HARMOINEN, A ; SISTO, T ; TARKKA, M ; METSÄ-KETELÄ, T ; IOVANNA, J. L ; DAGORN, J.-C ; NORDBACK, I. H</creatorcontrib><description>Antioxidants may reduce pancreatic cellular injury after coronary artery bypass grafting (CABG) Twenty patients (Group A) received vitamin E (600 mg/ day) for 28 days and vitamin C (2 g/day) and allopurinol (600 mg/day) 2 days before and 1 day after CABG. Seventeen patients (Group C) received all drugs for 3 days, and 25 (Group B) and 19 (Group D) patients served as corresponding controls. The pre- and postoperative pancreatic isoamylase (P-amylase), creatinine, and antioxidant concentrations were measured. Serum hyperamylasemia was highest on the first postoperative day and occurred in 73% of the patients. After surgery serum P-amylase increased in all study groups and urine P-amylase decreased. Postoperative serum hyperamylasemia, whether primarily renal or pancreatic, cannot be decreased by pretreatment with allopurinol, vitamin C, and vitamin E.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/00006676-199610000-00004</identifier><identifier>PMID: 8884843</identifier><identifier>CODEN: PANCE4</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Aged ; Allopurinol - therapeutic use ; Amylases - blood ; Antioxidants - therapeutic use ; Ascorbic Acid - therapeutic use ; Biological and medical sciences ; Coronary Artery Bypass - adverse effects ; Creatinine - blood ; Digestive system ; Female ; Humans ; Isoenzymes - blood ; Male ; Medical sciences ; Middle Aged ; Pancreas - enzymology ; Pharmacology. Drug treatments ; Postoperative Complications - prevention & control ; Prospective Studies ; Vitamin E - therapeutic use</subject><ispartof>Pancreas, 1996-10, Vol.13 (3), p.236-240</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-fc6a708f26096eaeed56d45a2d187ab9ac14b4810ea3fea40b18d95d20bb7b103</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3224457$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8884843$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PAAJANEN, H</creatorcontrib><creatorcontrib>HARMOINEN, A</creatorcontrib><creatorcontrib>SISTO, T</creatorcontrib><creatorcontrib>TARKKA, M</creatorcontrib><creatorcontrib>METSÄ-KETELÄ, T</creatorcontrib><creatorcontrib>IOVANNA, J. L</creatorcontrib><creatorcontrib>DAGORN, J.-C</creatorcontrib><creatorcontrib>NORDBACK, I. H</creatorcontrib><title>Effect of antioxidants on postoperative hyperamylasemia in Coronary bypass surgery</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>Antioxidants may reduce pancreatic cellular injury after coronary artery bypass grafting (CABG) Twenty patients (Group A) received vitamin E (600 mg/ day) for 28 days and vitamin C (2 g/day) and allopurinol (600 mg/day) 2 days before and 1 day after CABG. Seventeen patients (Group C) received all drugs for 3 days, and 25 (Group B) and 19 (Group D) patients served as corresponding controls. The pre- and postoperative pancreatic isoamylase (P-amylase), creatinine, and antioxidant concentrations were measured. Serum hyperamylasemia was highest on the first postoperative day and occurred in 73% of the patients. After surgery serum P-amylase increased in all study groups and urine P-amylase decreased. Postoperative serum hyperamylasemia, whether primarily renal or pancreatic, cannot be decreased by pretreatment with allopurinol, vitamin C, and vitamin E.</description><subject>Aged</subject><subject>Allopurinol - therapeutic use</subject><subject>Amylases - blood</subject><subject>Antioxidants - therapeutic use</subject><subject>Ascorbic Acid - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Coronary Artery Bypass - adverse effects</subject><subject>Creatinine - blood</subject><subject>Digestive system</subject><subject>Female</subject><subject>Humans</subject><subject>Isoenzymes - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pancreas - enzymology</subject><subject>Pharmacology. Drug treatments</subject><subject>Postoperative Complications - prevention & control</subject><subject>Prospective Studies</subject><subject>Vitamin E - therapeutic use</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UE1LxDAQDaKs6-pPEHIQb9WkSZP0KMv6AQuC6LlM2kQjbVOTVuy_t3XXncN8vjczPIQwJTeU5PKWTCaEFAnNc0HnKpkdP0JLmjGRcJWqY7QkSmUJo1KeorMYPwmhkmX5Ai2UUlxxtkQvG2tN2WNvMbS98z-ummLEvsWdj73vTIDefRv8Mc5pM9YQTeMAuxavffAthBHrsYMYcRzCuwnjOTqxUEdzsY8r9Ha_eV0_Jtvnh6f13TYpmVB9YksBkiibCpILA8ZUmah4BmlFlQSdQ0m55ooSA8wa4ERTVeVZlRKtpaaErdD1bm8X_NdgYl80LpamrqE1foiFVFwKpugEVDtgGXyMwdiiC66ZHi8oKWY5i385i4Ocfy0-US_3NwbdmOpA3Os3za_2c4gl1DZAW7p4gLE05TyT7BeRyH7K</recordid><startdate>19961001</startdate><enddate>19961001</enddate><creator>PAAJANEN, H</creator><creator>HARMOINEN, A</creator><creator>SISTO, T</creator><creator>TARKKA, M</creator><creator>METSÄ-KETELÄ, T</creator><creator>IOVANNA, J. L</creator><creator>DAGORN, J.-C</creator><creator>NORDBACK, I. H</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961001</creationdate><title>Effect of antioxidants on postoperative hyperamylasemia in Coronary bypass surgery</title><author>PAAJANEN, H ; HARMOINEN, A ; SISTO, T ; TARKKA, M ; METSÄ-KETELÄ, T ; IOVANNA, J. L ; DAGORN, J.-C ; NORDBACK, I. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-fc6a708f26096eaeed56d45a2d187ab9ac14b4810ea3fea40b18d95d20bb7b103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Aged</topic><topic>Allopurinol - therapeutic use</topic><topic>Amylases - blood</topic><topic>Antioxidants - therapeutic use</topic><topic>Ascorbic Acid - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Coronary Artery Bypass - adverse effects</topic><topic>Creatinine - blood</topic><topic>Digestive system</topic><topic>Female</topic><topic>Humans</topic><topic>Isoenzymes - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pancreas - enzymology</topic><topic>Pharmacology. Drug treatments</topic><topic>Postoperative Complications - prevention & control</topic><topic>Prospective Studies</topic><topic>Vitamin E - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PAAJANEN, H</creatorcontrib><creatorcontrib>HARMOINEN, A</creatorcontrib><creatorcontrib>SISTO, T</creatorcontrib><creatorcontrib>TARKKA, M</creatorcontrib><creatorcontrib>METSÄ-KETELÄ, T</creatorcontrib><creatorcontrib>IOVANNA, J. L</creatorcontrib><creatorcontrib>DAGORN, J.-C</creatorcontrib><creatorcontrib>NORDBACK, I. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PAAJANEN, H</au><au>HARMOINEN, A</au><au>SISTO, T</au><au>TARKKA, M</au><au>METSÄ-KETELÄ, T</au><au>IOVANNA, J. L</au><au>DAGORN, J.-C</au><au>NORDBACK, I. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of antioxidants on postoperative hyperamylasemia in Coronary bypass surgery</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>1996-10-01</date><risdate>1996</risdate><volume>13</volume><issue>3</issue><spage>236</spage><epage>240</epage><pages>236-240</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><coden>PANCE4</coden><abstract>Antioxidants may reduce pancreatic cellular injury after coronary artery bypass grafting (CABG) Twenty patients (Group A) received vitamin E (600 mg/ day) for 28 days and vitamin C (2 g/day) and allopurinol (600 mg/day) 2 days before and 1 day after CABG. Seventeen patients (Group C) received all drugs for 3 days, and 25 (Group B) and 19 (Group D) patients served as corresponding controls. The pre- and postoperative pancreatic isoamylase (P-amylase), creatinine, and antioxidant concentrations were measured. Serum hyperamylasemia was highest on the first postoperative day and occurred in 73% of the patients. After surgery serum P-amylase increased in all study groups and urine P-amylase decreased. Postoperative serum hyperamylasemia, whether primarily renal or pancreatic, cannot be decreased by pretreatment with allopurinol, vitamin C, and vitamin E.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>8884843</pmid><doi>10.1097/00006676-199610000-00004</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3177 |
ispartof | Pancreas, 1996-10, Vol.13 (3), p.236-240 |
issn | 0885-3177 1536-4828 |
language | eng |
recordid | cdi_proquest_miscellaneous_78476381 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Aged Allopurinol - therapeutic use Amylases - blood Antioxidants - therapeutic use Ascorbic Acid - therapeutic use Biological and medical sciences Coronary Artery Bypass - adverse effects Creatinine - blood Digestive system Female Humans Isoenzymes - blood Male Medical sciences Middle Aged Pancreas - enzymology Pharmacology. Drug treatments Postoperative Complications - prevention & control Prospective Studies Vitamin E - therapeutic use |
title | Effect of antioxidants on postoperative hyperamylasemia in Coronary bypass surgery |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A37%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20antioxidants%20on%20postoperative%20hyperamylasemia%20in%20Coronary%20bypass%20surgery&rft.jtitle=Pancreas&rft.au=PAAJANEN,%20H&rft.date=1996-10-01&rft.volume=13&rft.issue=3&rft.spage=236&rft.epage=240&rft.pages=236-240&rft.issn=0885-3177&rft.eissn=1536-4828&rft.coden=PANCE4&rft_id=info:doi/10.1097/00006676-199610000-00004&rft_dat=%3Cproquest_cross%3E78476381%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78476381&rft_id=info:pmid/8884843&rfr_iscdi=true |